Stay updated on Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial
Sign up to get notified when there's something new on the Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial page.

Latest updates to the Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now renders a 403 Forbidden error page instead of the study record. The new content shows a minimal header and a Home link, indicating the study details at this URL are inaccessible.SummaryDifference18%

- Check16 days agoChange DetectedThe page now displays a newer revision identifier, changing from v3.6.6 to v3.7.0. This reflects a backend/template update and does not modify the study details or content shown on the page.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a new revision of the study record.SummaryDifference0.1%

- Check37 days agoChange DetectedThe study record now displays a new NIH funding line, '2018 ( U.S. NIH Grant/Contract )', clarifying the source of support for the CARACAS trial.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a newer release of the page. The underlying study details, content and structure remain unchanged.SummaryDifference0.1%

- Check73 days agoChange DetectedThe study record shows a new revision: v3.6.4 replacing the previous v3.6.3. This indicates a small, non-substantive update to the page’s content or metadata.SummaryDifference0.1%

Stay in the know with updates to Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial page.